- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
The INI-1 gene, which encodes a functionally uncharacterized protein component of the hSWI/SNF chromatin remodeling complex, is often mutated or deleted in malignant rhabdoid tumor (MRT). Two isoforms of INI-1, that differ by the variable inclusion of amino acids, potentially are produced by differential RNA splicing. The morphology of MRTs can present challenges in differential diagnosis. The overall survival of MRTs relative to its potential mimics (medulloblastoma, supratentorial primitive neuroectodermal tumors (sPNETs) is quite low, and thus differentiation from these other tumors is desirable. Lack of nuclear labeling by anti-INI-1 is characteristic of MRT. The majority of medulloblastomas and sPNETs are labeled by anti-INI-1. MRTs also originate from the kidney and soft tissues.
For an antibody with protein microarray specificity validation, see our INI1 Antibody SMARCB1/3984.
Optimal dilution of the Integrase interactor 1 Antibody SMARCB1/8851R should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 1-200) from the human protein was used as the immunogen for the Integrase interactor 1 Antibody SMARCB1/8851R.
Aliquot the Integrase interactor 1 Antibody SMARCB1/8851R and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
INI1 antibody, SMARCB1 antibody, BAF47 antibody, SNF5 antibody, hSNF5 antibody, INI-1 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.